ARTA
MBIO icon

A.R.T. Advisors’s Mustang Bio MBIO Stock Holding History

A.R.T. Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-35
Closed -$107K – 593
2019
Q4 		$107K Sell
35
-4
-10% -$9.16K 0.01% 1208
2019
Q3 		$95K Buy
+39
New +$107K ﹤0.01% 1268
2018
Q2 		– Sell
-23
Closed -$186K – 1628
2018
Q1 		$186K Buy
+23
New +$196K 0.01% 1282

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

A.R.T. Advisors's MBIO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Mustang Bio (MBIO) in Q1 2020, closing a stake of 35 shares — an estimated $107K sold.

A.R.T. Advisors first reported a position in MBIO in Q1 2018 and held it in 3 quarters. The position peaked at $186K in Q1 2018. 64 funds tracked by Wall St. Rank hold MBIO as of Q1 2020.

  • A.R.T. Advisors reported no remaining Mustang Bio position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 35 Mustang Bio shares in Q1 2020, an estimated $107K.
  • A.R.T. Advisors first reported a position in Mustang Bio in Q1 2018 and held it in 3 quarters.
  • A.R.T. Advisors's Mustang Bio position peaked at $186K in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.